Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

AstraZeneca, Mitsubishi Tanabe Pharma present new relaxin receptor 1 agonists

July 7, 2022

Walden Biosciences enters research collaboration with University of Michigan on suPAR genetics

July 6, 2022

SAN-903 dampens renal fibrosis in mouse model of chronic kidney disease

June 27, 2022

Southern Research Institute and UABRF report development of HO-1 modulators

June 8, 2022

New K(Ca) 1.1 channel activators identified at Gwangju Institute of Science and Technology

May 5, 2022

Novel TRPC5 inhibitors show potential for the treatment of CKD

May 3, 2022

ZLD-2218, a novel BRD4 inhibitor for the treatment of kidney fibrosis

April 26, 2022

Eloxx expands ELX-02 development program to include Alport syndrome

March 31, 2022

The role of DNA-PKcs and Fis1 in acute kidney injury pathogenesis

March 22, 2022

Vertex Pharmaceuticals synthesizes new APOL1 inhibitors

March 21, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...